Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui Hui Liu

Showing results (131-140 of 178) with videos related to

Pageof 18
Sort By:
Clinical and Experimental Medicine|January 9, 2019
Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysmYue Wu, Fei Fei Liu, Yao Xu, et al.
Pediatric Rheumatology Online Journal|August 2, 2019
The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki diseaseSama Samadli, Fei Fei Liu, Goshgar Mammadov, et al.
Lipids in Health and Disease|October 23, 2024
Free fatty acids: independent predictors of long-term adverse cardiovascular outcomes in heart failure patientsGuang-Zhi Liao, Hui-Hui Liu, Chun-Hui He, et al.
Archives of Dermatological Research|July 21, 2005
Polymorphisms in the promoter region of RANTES in Han Chinese and their relationship with systemic lupus erythematosusDong Qing Ye, Shi Gui Yang, Xiang Pei Li, et al.
European Journal of Clinical Investigation|February 16, 2020
Clinical observation of noncoronary cardiac abnormalities in Chinese children with Kawasaki diseaseFei Fei Liu, Hui Hui Liu, Zhen Qiu, et al.
Atherosclerosis|June 18, 2017
High-density lipoprotein cholesterol levels are associated with coronary severity but not with outcomes in new-onset patients with stable coronary artery diseaseHui-Hui Liu, Yuan-Lin Guo, Na-Qiong Wu, et al.
Atherosclerosis|November 5, 2019
Baseline and on-statin treatment lipoprotein(a) levels for predicting cardiovascular events in patients with familial hypercholesterolemiaYe-Xuan Cao, Jing-Lu Jin, Yuan-Lin Guo, et al.
Atherosclerosis|September 1, 2018
The different relations of PCSK9 and Lp(a) to the presence and severity of atherosclerotic lesions in patients with familial hypercholesterolemiaYe-Xuan Cao, Hui-Hui Liu, Di Sun, et al.
Pediatric Research|September 29, 2021
A new scoring system for coronary artery abnormalities in Kawasaki diseaseHui Hui Liu, Wei Xia Chen, Man Man Niu, et al.
Annals of Translational Medicine|May 14, 2021
Visit-to-visit variability of lipid and cardiovascular events in patients with familial hypercholesterolemiaYe-Xuan Cao, Liang Li, Hui-Wen Zhang, et al.
Pageof 18

Showing results (131-140 of 178) with videos related to

Sort By:
Pageof 18
Clinical and Experimental Medicine|January 9, 2019
Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysmYue Wu, Fei Fei Liu, Yao Xu, et al.
Pediatric Rheumatology Online Journal|August 2, 2019
The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki diseaseSama Samadli, Fei Fei Liu, Goshgar Mammadov, et al.
Lipids in Health and Disease|October 23, 2024
Free fatty acids: independent predictors of long-term adverse cardiovascular outcomes in heart failure patientsGuang-Zhi Liao, Hui-Hui Liu, Chun-Hui He, et al.
Archives of Dermatological Research|July 21, 2005
Polymorphisms in the promoter region of RANTES in Han Chinese and their relationship with systemic lupus erythematosusDong Qing Ye, Shi Gui Yang, Xiang Pei Li, et al.
European Journal of Clinical Investigation|February 16, 2020
Clinical observation of noncoronary cardiac abnormalities in Chinese children with Kawasaki diseaseFei Fei Liu, Hui Hui Liu, Zhen Qiu, et al.
Atherosclerosis|June 18, 2017
High-density lipoprotein cholesterol levels are associated with coronary severity but not with outcomes in new-onset patients with stable coronary artery diseaseHui-Hui Liu, Yuan-Lin Guo, Na-Qiong Wu, et al.
Atherosclerosis|November 5, 2019
Baseline and on-statin treatment lipoprotein(a) levels for predicting cardiovascular events in patients with familial hypercholesterolemiaYe-Xuan Cao, Jing-Lu Jin, Yuan-Lin Guo, et al.
Atherosclerosis|September 1, 2018
The different relations of PCSK9 and Lp(a) to the presence and severity of atherosclerotic lesions in patients with familial hypercholesterolemiaYe-Xuan Cao, Hui-Hui Liu, Di Sun, et al.
Pediatric Research|September 29, 2021
A new scoring system for coronary artery abnormalities in Kawasaki diseaseHui Hui Liu, Wei Xia Chen, Man Man Niu, et al.
Annals of Translational Medicine|May 14, 2021
Visit-to-visit variability of lipid and cardiovascular events in patients with familial hypercholesterolemiaYe-Xuan Cao, Liang Li, Hui-Wen Zhang, et al.
Pageof 18